EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.

Cited by papers we hold 4

• The Role of Exosomes and Their Applications in Cancer · 2021
  No notice
• Exosome-based immunotherapy: a promising approach for cancer treatment · 2020
  No notice
• The enigmatic seminal plasma: a proteomics insight from ejaculation to fertilization · 2018
  No notice
• FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.